Patient-specific thyroid computational models and SIMIND Monte Carlo simulations for assessing the accuracy of 131I dosimetry in hyperthyroidism

Authors

  • Enzo Hilario Aman National University of La Plata image/svg+xml
    • Data Curation
    • Formal Analysis
    • Investigation
    • Methodology
    • Writing – Review & Editing
  • Cecilia Yamil Chain National University of La Plata image/svg+xml
    • Conceptualization
    • Formal Analysis
    • Methodology
    • Supervision
    • Writing – Original Draft Preparation
    • Writing – Review & Editing
  • Luis Héctor Illanes National University of La Plata image/svg+xml
    • Formal Analysis
    • Investigation
    • Methodology
    • Supervision

DOI:

https://doi.org/10.15392/2319-0612.2026.3138

Keywords:

SIMIND MC, patient- specific thyroid phantom, goitre, thyroid absorbed dose

Abstract

The aim of this study was to use SIMIND Monte Carlo (MC) simulations together with patient-specific thyroid computational models to assess the accuracy of 131I- activity quantification from planar images and thyroid dosimetry calculations in radiopharmaceutical therapy with [131I] sodium iodide for hyperthyroidism. The methodology integrates two components: (i) patient- specific thyroid computational models of big and medium goitre, generated by processing patient computed tomography scans with 3D Slicer Image computing software; and (ii) a virtual gamma camera created using SIMIND MC code. The modelled Picker Prism 2000 XP gamma camera was used to obtain planar images of the patient- specific thyroid computational models, in which a predefined 131I activity of 1.665 MBq was assigned to the thyroid volume, using a high- energy collimator and a distance thyroid/ detector of 5 cm, as clinically representative imaging conditions. The same acquisition parameters were used to obtain simulated planar images of the Zubal reference phantom and a calibration source, with the aim of quantification. Dosimetry calculations were based on a monocompartmental 131I biodistribution model, assuming a post- administration time of 24 hours, and an effective elimination time of 5.5 days. With the proposed methodological framework, two patient- specific thyroid computational models of goitre have been successfully implemented, yielding with SIMIND MC realistic, patient-morphed thyroid scintigraphies. Thyroid activity was quantified with 3% error for the Zubal phantom and ≤0.4% error for the patient-specific computational models, that propagated without modification to the absorbed dose values. The results showed that self-irradiation absorbed dose in the thyroid strongly depends on the thyroid mass that is considered, exhibiting dose values for the medium- goitre that doubled the values for the big goitre, and slightly varies with the nature of the computational model. The study illustrates the utility of SIMIND MC simulations together with thyroid computational models to estimate the accuracy of the dosimetry calculation that could emerge in a realistic clinical setting and to identify the influence of the image acquisition parameters and the thyroid mass in the calculation accuracy.

Downloads

Download data is not yet available.

References

[1] R ROSS, D. S.; BURCH, H. B.; COOPER, D. S. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, New Rochelle, NY, US, v. 26, n. 10, p. 1343-1421, 2016 DOI: https://doi.org/10.1089/thy.2016.0229

[2] European Association of Nuclear Medicine. European Nuclear Medicine Guide, Chapter 5.2, Na[131I]I for Thyroid Benign Diseases. Disponível em: https://nucmed-guide.app/chapter/302. Acesso em: 1 jun. 2026.

[3] HÄNSCHEID, H.; CANZI, C.; ESCHNER, W. et al. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II: Dosimetry prior to radioiodine therapy of benign thyroid diseases. European Journal of Nuclear Medicine and Molecular Imaging, London, UK, v. 40, n. 7, p. 1126-1134, 2013. DOI: https://doi.org/10.1007/s00259-013-2387-x

[4] GEAR, J.; STOKKE, C.; TERWINGHE, C.; GNESIN, S. et al. EANM enabling guide: how to improve the accessibility of clinical dosimetry. European Journal of Nuclear Medicine and Molecular Imaging, London, UK, v. 50, n. 7, p. 1861-1868, 2023. DOI: https://doi.org/10.1007/s00259-023-06226-z

[5] IIZUKA, Y.; KATAGIRI, T.; INOUE, M. et al. Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy. Scientific Reports, London, UK, v. 11, n. 1, 21858, 2021. DOI: https://doi.org/10.1038/s41598-021-01432-x

[6] LJUNGBERG, M. The SIMIND Monte Carlo Program Version 6.2. Lund University, Medical Radiation Physics, Department of Clinical Sciences, Lund, Sweden, 2020.

[7] CHATZISAVVAS, N.; PRINIOTAKIS, G.; PAPOUTSIDAKIS, M. et al. Monte Carlo computational software and methods in radiation dosimetry. Annals of Emerging Technologies in Computing (AETiC), London, UK, v. 5, n. 3, p. 36-51, 2021. DOI: https://doi.org/10.33166/AETiC.2021.03.004

[8] ORAMAS POLO, I. Simulation of the functioning of a gamma camera using Monte Carlo method. Revista de Física Médica, Madrid, Spain, v. 15, n. 1, p. 21-28, 2014.

[9] MORPHIS, M.; VAN STADEN, J. A.; DU RAAN, H.; LJUNGBERG, M. Validation of a SIMIND Monte Carlo modelled gamma camera for Iodine-123 and Iodine-131 imaging. Heliyon, London, UK, v. 7, n. 6, e07196, 2021. DOI: https://doi.org/10.1016/j.heliyon.2021.e07196

[10] DE LA CRUZ MARIN, J. L.; CHAIN, C. Y.; ILLANES, L. H. Modelo computacional de una cámara gama como simulador de imágenes clínicas. Anales AFA, Buenos Aires, Argentina, v. 36, n. 2, p. 1-1, 2025.

[11] DAISAKI, H.; KUBOTA, C.; ISHIKAWA, K. et al. Validation of Quantitative Accuracy and Variability in 177Lu Imaging Using Monte Carlo Simulation. Nihon Hoshasen Gijutsu Gakkai Zasshi, Kyoto, Japan, v. 80, n. 6, p. 593-604, 2024. DOI: https://doi.org/10.6009/jjrt.2024-1451

[12] DE LA CRUZ MARIN, J. L.; CHAIN, C. Y.; ILLANES, L. H. Exactitud en la cuantificación de la actividad de 131I a partir de imágenes SPECT: un estudio SIMIND monte carlo. Anales AFA, Buenos Aires, Argentina, v. 37, n. 1, p. 1-5, 2026. DOI: https://doi.org/10.31527/analesafa.2026.37.1.1-5

[13] RAMONAHENG, K.; VAN STADEN, J. A.; DU RAAN, H. The effect of calibration factors and recovery coefficients on 177Lu SPECT activity quantification accuracy: a Monte Carlo study. EJNMMI Physics, London, UK, v. 8, p. 27, 2021. DOI: https://doi.org/10.1186/s40658-021-00365-8

[14] MORPHIS, M.; VAN STADEN, J. A.; DU RAAN, H.; LJUNGBERG, M.; SJÖGREEN GLEISNER, K. Accuracy of patient-specific 131I dosimetry using hybrid whole-body planar-SPECT/CT 123I and 131I imaging. EJNMMI Physics, London, UK, v. 11, p. 50, 2024. DOI: https://doi.org/10.1186/s40658-024-00657-9

[15] LJUNGBERG, M.; DEWARAJA, Y. K. The use of Monte Carlo simulations to evaluate image-based absorbed dose calculation procedures. In: ZAIDI, H. (Ed.). Monte Carlo Calculations in Nuclear Medicine (Second Edition) Therapeutic applications, Bristol, UK: IOP Publishing, 2022. p. 20.1-20.26. ISBN 978-0-7503-2692-6.

[16] VITALLER, M. J. Evaluación de métodos de cuantificación de actividad de 131 I a partir de imágenes bidimensionales: Análisis comparativo utilizando SIMIND MC. Doctoral dissertation. Universidad Nacional de La Plata, La Plata, Argentina, 2025.

[17] CALANDRÓN, V. M. Utilidad de las simulaciones basadas en Montecarlo para la implementación de cálculos dosimétricos en tratamientos de hipertiroidismo Doctoral dissertation. Universidad Nacional de La Plata, La Plata, Argentina, 2026.

[18] VITALLER, M. J.; AMAN, E.; DE LA CRUZ MARIN, J. L.; CALANDRÓN, V. M.; CHAIN, C. Y.; ILLANES, L. H. Computational simulation of nuclear medicine images in patients with thyroid diseases. In: Memorias del Simposio de Modelado y Simulación (SIMS 2026)-JAIIO 55 2026, La Plata, Argentina. Memorias: La Plata, Argentina: Sociedad Argentina de Informática e Investigación Operativa (SADIO), 2026.

[19] FRANKLYN, J.; SHEPHARD, M. Evaluation of thyroid function in health and disease. Disponível em: https://www.endotext.org/. Acesso em: 15 set. 2026.

[20] KOBE, C.; ESCHNER, W.; WILD, M. et al. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?. Nuclear Medicine Communications, London, UK, v. 31, n. 3, p. 201-205, 2010. DOI: https://doi.org/10.1097/MNM.0b013e328333d303

[21] ANDERSSON, M.; MATTSSON, S. Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases. Frontiers in Endocrinology, Lausanne, Switzerland, v. 12, 634955, 2021. DOI: https://doi.org/10.3389/fendo.2021.634955

[22] PÉREZ, J. M.; ORELLANA SALAS, A.; GUARDIOLA, Y. S. Comparación dosimétrica entre actividad fija y actividad individualizada en el tratamiento de la enfermedad de Graves con I-131. Revista de Física Médica, Madrid, Spain, v. 14, n. 2, p. 123-130, 2013.

[23] GEAR, J. I.; COX, M. G.; GUSTAFSSON, J. et al. EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. European Journal of Nuclear Medicine and Molecular Imaging, London, UK, v. 45, n. 13, p. 2456-2474, 2018. DOI: https://doi.org/10.1007/s00259-018-4136-7

Downloads

Published

2026-11-20

Data Availability Statement

Derived data supporting the conclusions of this study are available upon request from the corresponding author.

Issue

Section

Original Article